Revolutionizing Recovery: The Dawn of Stem Cell Therapy for Spinal Cord Injuries
In an era where medical breakthroughs are increasingly becoming the norm, a recent study by the Mayo Clinic, showcased on Good Morning America, stands out as a beacon of hope for individuals suffering from spinal cord injuries. This groundbreaking research illuminates the potent potential of stem cell therapy in forging new paths toward recovery and […]
BrainStorm Cell Therapeutics Partners with NEALS, The ALS Association, and I AM ALS to Provide Public Access to Biospecimens from NurOwn’s Phase 3 ALS Study
NEW YORK, Jan. 10, 2023 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that BCLI will donate biospecimens from NurOwn’s placebo-controlled Phase 3 ALS trial to the Northeast Amyotrophic Lateral Sclerosis Consortium (NEALS) biorepository for use by the research community. The specimens are being submitted to the […]